Should sporicidal agents be ammunition in the C. diff fight?

Hospitals across the country struggle with keeping Clostridium difficile at bay — according to Consumer Reports‘ recent rankings, more than one-third of U.S. hospitals had C. diff rates worse than the national benchmark.

Advertisement

One of the reasons C. diff rates are so difficult to control is because C. diff itself is persistent and hard to kill. For instance, alcohol-based hand sanitizer cannot kill the bacteria; instead, soap and water must be used. Additionally, standard Environmental Protection Agency-registered hospital disinfectants are not effective against C. diff, according to the CDC.

In fact, the CDC recommends using an EPA-registered disinfectant with a sporicidal claim to clean and disinfect surfaces and devices to control the spread of C. diff.

Learn more about the indiscriminate use of sporicidal agents to fight C. diff in an upcoming webinar, sponsored by Clorox. Register for the Nov. 1 webinar here.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.